In the time of COVID-19, predictive molecular pathology laboratories must still timely select oncological patients for targeted treatments. However, the need to respect social distancing measures may delay results generated by laboratory-developed tests based on sequential steps a long hands-on time. Laboratory workflows should now be simplified.
Predictive molecular pathology in the time of COVID-19 / Malapelle, U., De Luca, C., Iaccarino, A., Pepe, F., Pisapia, P., Russo, M., Sgariglia, R., Nacchio, M., Vigliar, E., Bellevicine, C., Schmitt, F.C., Troncone, G.. - In: JOURNAL OF CLINICAL PATHOLOGY. - ISSN 0021-9746. - 74:4(2021), pp. 234-237. [10.1136/jclinpath-2020-206711]
Predictive molecular pathology in the time of COVID-19
Malapelle, Umberto;De Luca, Caterina;Iaccarino, Antonino;Pepe, Francesco;Pisapia, Pasquale;Russo, Maria;Sgariglia, Roberta;Nacchio, Mariantonia;Vigliar, Elena;Bellevicine, Claudio;Troncone, Giancarlo
2021
Abstract
In the time of COVID-19, predictive molecular pathology laboratories must still timely select oncological patients for targeted treatments. However, the need to respect social distancing measures may delay results generated by laboratory-developed tests based on sequential steps a long hands-on time. Laboratory workflows should now be simplified.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
